Charles Parks Richardson, MD, MBA - Co-Founder and President of Products
Dr. Richardson is the Co-Founder and President of Products and Board of Directors Member for Cleveland Heart Corporation, in Cleveland, Ohio - the medical technology is focused on Ventricular Assist Device, or VAD, a mechanical device that is used to partially or completely replace the function of a failing heart. Dr. Richardson earned his M.D. with honors from Central America Health Sciences University School of Medicine. Dr. Richardson received his BS degree in Chemistry from the Winston-Salem State University in Winston-Salem, North Carolina.
Dr. Richardson holds a MBA at the University of South Carolina (Moore School of Business). Moore School is perhaps best known for its outstanding leadership in international business education and research. For the past thirteen years, the school's undergraduate major in international business has been ranked No. 1 in that specialty, and its International Master of Business Administration program has been ranked No. 1 or No. 2 for 20 consecutive years by U.S. News & World Report. In 2009, the Financial Times of London ranked the school's MBA programs at No. 38 among U.S. universities-ahead of institutions such as Ohio State University, Wake Forest University, and the University of Notre Dame. The school is home to several leading journals, including the Economics of Education Review. In 1990, the U.S. Department of Education selected the Moore School as one of five educational institutions in the country, and the only one in the Southeast, to serve as a Center for International Business and Education Research (CIBER).
Dr. Richardson has been primarily responsible for raising millions in private and public capital for the companies that he has co-founded. In addition to the companies that he has co-founded, Dr. Richardson has made private investments in the initial equity financing of over five start up companies and has served on Board of Director member in early stage life science companies.
Dr. Richardson is the Co-Founder and President of Products and Board of Directors Member for Cleveland Heart Corporation, in Cleveland, Ohio - the medical technology is focused on Ventricular Assist Device, or VAD, a mechanical device that is used to partially or completely replace the function of a failing heart. Dr. Richardson earned his M.D. with honors from Central America Health Sciences University School of Medicine. Dr. Richardson received his BS degree in Chemistry from the Winston-Salem State University in Winston-Salem, North Carolina.
Dr. Richardson holds a MBA at the University of South Carolina (Moore School of Business). Moore School is perhaps best known for its outstanding leadership in international business education and research. For the past thirteen years, the school's undergraduate major in international business has been ranked No. 1 in that specialty, and its International Master of Business Administration program has been ranked No. 1 or No. 2 for 20 consecutive years by U.S. News & World Report. In 2009, the Financial Times of London ranked the school's MBA programs at No. 38 among U.S. universities-ahead of institutions such as Ohio State University, Wake Forest University, and the University of Notre Dame. The school is home to several leading journals, including the Economics of Education Review. In 1990, the U.S. Department of Education selected the Moore School as one of five educational institutions in the country, and the only one in the Southeast, to serve as a Center for International Business and Education Research (CIBER).
Dr. Richardson has been primarily responsible for raising millions in private and public capital for the companies that he has co-founded. In addition to the companies that he has co-founded, Dr. Richardson has made private investments in the initial equity financing of over five start up companies and has served on Board of Director member in early stage life science companies.
Franz Kellar, M.B.A., Co-Founder and President of Operations and Technology
Franz Kellar, M.B.A., Co-Founder and President of Operations and Technology, B.S.M.E., North Carolina State University; graduating Magna Cum Laude in 1985. He was awarded SME; Young Engineer Award in 1992, a national engineering award. Mr. Kellar earned a M.B.A. from Duke University in 2001 and has spent most of his career as a Licensed Professional Engineer and professional manager. Mr. Kellar specializes in intellectual property development, medical product early stage corporate development and management. Mr. Kellar has contributed to development efforts for mechanical heart assist devices. Mr Kellar is a partner of BioMedFlex LLC - a company that produces a proprietary flexural hard carbon thin film nanotechnology that provides superior wear resistance and biocompatible surface integrity for medical applications.
Franz Kellar, M.B.A., Co-Founder and President of Operations and Technology, B.S.M.E., North Carolina State University; graduating Magna Cum Laude in 1985. He was awarded SME; Young Engineer Award in 1992, a national engineering award. Mr. Kellar earned a M.B.A. from Duke University in 2001 and has spent most of his career as a Licensed Professional Engineer and professional manager. Mr. Kellar specializes in intellectual property development, medical product early stage corporate development and management. Mr. Kellar has contributed to development efforts for mechanical heart assist devices. Mr Kellar is a partner of BioMedFlex LLC - a company that produces a proprietary flexural hard carbon thin film nanotechnology that provides superior wear resistance and biocompatible surface integrity for medical applications.
Chris Coburn- Executive Director, Cleveland Clinic Innovations - Board Member
Chris Coburn, Executive Director. Chris Coburn is Cleveland Clinic's chief of technology commercialization, serving as Executive Director of Cleveland Clinic Innovations since it was established in 2000. Under his leadership, Cleveland Clinic has become a national leader in commercial innovation with 30 spin-offs, more than $200 million in follow on equity investment, 200 licenses and $135 million in applied research and commercialization grants . He has recruited a top performing team guided by some of the nation's top venture capitalists. Mr. Coburn serves on the board of directors of Autonomic Technologies, Cleveland Heart, PeriTec, and PrognostiX. He is a member of the Ohio's 3rd Frontier Advisory Board and a trustee of Cuyahoga Arts and Culture, Hathaway Brown School, and the City Club of Cleveland He was selected in 2008 by Neurotech Business Reports as the most valuable financial professional and has consulted, testified and spoken on technology commercialization throughout North America and more than 20 countries.
He is a former Vice President and General Manager of Battelle Memorial Institute, director of the U.S. Enrichment Corporation (NYSE:USU) and author of numerous articles and book chapters. He and his wife Nancy and their three children live in Shaker Heights, Ohio.
Chris Coburn, Executive Director. Chris Coburn is Cleveland Clinic's chief of technology commercialization, serving as Executive Director of Cleveland Clinic Innovations since it was established in 2000. Under his leadership, Cleveland Clinic has become a national leader in commercial innovation with 30 spin-offs, more than $200 million in follow on equity investment, 200 licenses and $135 million in applied research and commercialization grants . He has recruited a top performing team guided by some of the nation's top venture capitalists. Mr. Coburn serves on the board of directors of Autonomic Technologies, Cleveland Heart, PeriTec, and PrognostiX. He is a member of the Ohio's 3rd Frontier Advisory Board and a trustee of Cuyahoga Arts and Culture, Hathaway Brown School, and the City Club of Cleveland He was selected in 2008 by Neurotech Business Reports as the most valuable financial professional and has consulted, testified and spoken on technology commercialization throughout North America and more than 20 countries.
He is a former Vice President and General Manager of Battelle Memorial Institute, director of the U.S. Enrichment Corporation (NYSE:USU) and author of numerous articles and book chapters. He and his wife Nancy and their three children live in Shaker Heights, Ohio.
Dave Vorhoff - Advisor to Board of Directors
Dave Vorhoff is a Managing Director and co-founding Partner of McColl Partners. Mr. Vorhoff serves as the head of the firm's Healthcare Group. Previously, he was a Managing Director of Banc of America Securities in New York, one of the leading healthcare investment banks in the country. He was also a Managing Director of NationsBanc Montgomery Securities in New York, and Managing Director of NationsBank Capital Markets' mergers and acquisitions group in Charlotte, North Carolina. During his 20 years of investment banking experience, Mr. Vorhoff has executed over 200 advisory and financing assignments in such industries as healthcare, retail, business services, apparel and textiles, printing and packaging, building products, financial services, and diversified manufacturing. Mr. Vorhoff serves on the Board of Directors of Sonic Automotive and previously on the Board of Directors of Star Scientific and several private companies. A Phi Beta Kappa graduate from The University of North Carolina at Chapel Hill, he also received a master of business administration degree from The Kenan-Flagler Business School at The University of North Carolina at Chapel Hill and was a member of Beta Gamma Sigma Honor Society.
Dave Vorhoff is a Managing Director and co-founding Partner of McColl Partners. Mr. Vorhoff serves as the head of the firm's Healthcare Group. Previously, he was a Managing Director of Banc of America Securities in New York, one of the leading healthcare investment banks in the country. He was also a Managing Director of NationsBanc Montgomery Securities in New York, and Managing Director of NationsBank Capital Markets' mergers and acquisitions group in Charlotte, North Carolina. During his 20 years of investment banking experience, Mr. Vorhoff has executed over 200 advisory and financing assignments in such industries as healthcare, retail, business services, apparel and textiles, printing and packaging, building products, financial services, and diversified manufacturing. Mr. Vorhoff serves on the Board of Directors of Sonic Automotive and previously on the Board of Directors of Star Scientific and several private companies. A Phi Beta Kappa graduate from The University of North Carolina at Chapel Hill, he also received a master of business administration degree from The Kenan-Flagler Business School at The University of North Carolina at Chapel Hill and was a member of Beta Gamma Sigma Honor Society.
Franz Kellar, M.B.A., Co-Founder and President of Operations and Technology
Franz Kellar, M.B.A., Co-Founder and President of Operations and Technology, B.S.M.E., North Carolina State University; graduating Magna Cum Laude in 1985. He was awarded SME; Young Engineer Award in 1992, a national engineering award. Mr. Kellar earned a M.B.A. from Duke University in 2001 and has spent most of his career as a Licensed Professional Engineer and professional manager. Mr. Kellar specializes in intellectual property development, medical product early stage corporate development and management. Mr. Kellar has contributed to development efforts for mechanical heart assist devices. Mr Kellar is a partner of BioMedFlex LLC - a company that produces a proprietary flexural hard carbon thin film nanotechnology that provides superior wear resistance and biocompatible surface integrity for medical applications.
Franz Kellar, M.B.A., Co-Founder and President of Operations and Technology, B.S.M.E., North Carolina State University; graduating Magna Cum Laude in 1985. He was awarded SME; Young Engineer Award in 1992, a national engineering award. Mr. Kellar earned a M.B.A. from Duke University in 2001 and has spent most of his career as a Licensed Professional Engineer and professional manager. Mr. Kellar specializes in intellectual property development, medical product early stage corporate development and management. Mr. Kellar has contributed to development efforts for mechanical heart assist devices. Mr Kellar is a partner of BioMedFlex LLC - a company that produces a proprietary flexural hard carbon thin film nanotechnology that provides superior wear resistance and biocompatible surface integrity for medical applications.
Charles Parks Richardson, MD, MBA - Co-Founder and President of Products
Dr. Richardson is the Co-Founder and President of Products and Board of Directors Member of Cleveland Heart, in Cleveland, Ohio - the medical technology is focused on Ventricular Assist Device, or VAD, a mechanical device that is used to partially or completely replace the function of a failing heart.
Dr. Richardson earned his M.D. with honors from Central America Health Sciences University School of Medicine. Dr. Richardson received his BS degree in Chemistry from the Winston-Salem State University in Winston-Salem, North Carolina.
Dr. Richardson holds a MBA at the University of South Carolina (Moore School of Business). Moore School is perhaps best known for its outstanding leadership in international business education and research. For the past thirteen years, the school's undergraduate major in international business has been ranked No. 1 in that specialty, and its International Master of Business Administration program has been ranked No. 1 or No. 2 for 20 consecutive years by U.S. News & World Report. In 2009, the Financial Times of London ranked the school's MBA programs at No. 38 among U.S. universities-ahead of institutions such as Ohio State University, Wake Forest University, and the University of Notre Dame. The school is home to several leading journals, including the Economics of Education Review. In 1990, the U.S. Department of Education selected the Moore School as one of five educational institutions in the country, and the only one in the Southeast, to serve as a Center for International Business and Education Research (CIBER).
Dr. Richardson has been primarily responsible for raising millions in private and public capital for the companies that he has co-founded. In addition to the companies that he has co-founded, Dr. Richardson has made private investments in the initial equity financing of over five start up companies and has served on Board of Director member in early stage life science companies.
Specialties
Dr. Richardson founded and served as Chief Operating Officer of IntelliServices, Inc., a technology company offering remote electronic medical records services through Care Link solutions. IntelliServices enabled medical staff to access information on patients with pacemakers and implants over the Internet.
Dr. Richardson has partnerships with world-class multi-specialty academic medical centers that integrates clinical and hospital care with research and education.
Dr. Richardson is the Co-Founder and President of Products and Board of Directors Member of Cleveland Heart, in Cleveland, Ohio - the medical technology is focused on Ventricular Assist Device, or VAD, a mechanical device that is used to partially or completely replace the function of a failing heart.
Dr. Richardson earned his M.D. with honors from Central America Health Sciences University School of Medicine. Dr. Richardson received his BS degree in Chemistry from the Winston-Salem State University in Winston-Salem, North Carolina.
Dr. Richardson holds a MBA at the University of South Carolina (Moore School of Business). Moore School is perhaps best known for its outstanding leadership in international business education and research. For the past thirteen years, the school's undergraduate major in international business has been ranked No. 1 in that specialty, and its International Master of Business Administration program has been ranked No. 1 or No. 2 for 20 consecutive years by U.S. News & World Report. In 2009, the Financial Times of London ranked the school's MBA programs at No. 38 among U.S. universities-ahead of institutions such as Ohio State University, Wake Forest University, and the University of Notre Dame. The school is home to several leading journals, including the Economics of Education Review. In 1990, the U.S. Department of Education selected the Moore School as one of five educational institutions in the country, and the only one in the Southeast, to serve as a Center for International Business and Education Research (CIBER).
Dr. Richardson has been primarily responsible for raising millions in private and public capital for the companies that he has co-founded. In addition to the companies that he has co-founded, Dr. Richardson has made private investments in the initial equity financing of over five start up companies and has served on Board of Director member in early stage life science companies.
Specialties
Dr. Richardson founded and served as Chief Operating Officer of IntelliServices, Inc., a technology company offering remote electronic medical records services through Care Link solutions. IntelliServices enabled medical staff to access information on patients with pacemakers and implants over the Internet.
Dr. Richardson has partnerships with world-class multi-specialty academic medical centers that integrates clinical and hospital care with research and education.
Harold Crowder, Jr., M.B.A., Director of Engineering
Harold has a B.S. Mechanical Engineering from North Carolina State University. Mr. Crowder earned a M.B.A. from UNCC and has spent most of his career as a Licensed Professional Engineer near Charlotte, North Carolina. Harold began his career working in the field of process and factory automation. Later he served as VP of Engineering at a leading manufacturer of multi-axis precision computer numerical controlled grinding, laser, and waterjet systems; serving Fortune 100 manufacturers in the medical, aerospace, materials, and industrial industries. Harold has led a variety of engineering teams in successful programs relating to product design, regulatory compliance, and quality system implementation.
Harold has a B.S. Mechanical Engineering from North Carolina State University. Mr. Crowder earned a M.B.A. from UNCC and has spent most of his career as a Licensed Professional Engineer near Charlotte, North Carolina. Harold began his career working in the field of process and factory automation. Later he served as VP of Engineering at a leading manufacturer of multi-axis precision computer numerical controlled grinding, laser, and waterjet systems; serving Fortune 100 manufacturers in the medical, aerospace, materials, and industrial industries. Harold has led a variety of engineering teams in successful programs relating to product design, regulatory compliance, and quality system implementation.
Leonard Golding, MB, BS, FRACS, FRCS(C), FACC - Chief Medical Officer
Leonard Golding is a Staff physician in the Department of Thoracic and Cardiovascular Surgery at Cleveland Clinic's main campus. He has held this position since 1977. Dr. Golding is also on Staff in the Department of Biomedical Engineering at Cleveland Clinic. Prior to 1997, he was an associate staff physician in Department of Thoracic and Cardiovascular Surgery at Cleveland Clinic. Dr. Golding is an international speaker and published author. His research has been published in leading peer-reviewed journals and he has contributed chapters to medical textbooks in his field.
Dr. Golding is a member of the American Association for Advancement of Science, American College of Cardiology, American Heart Association, American Institute for Medical & Biological Engineering, American Medical Association, American Society for Artificial Internal Organs, Royal Australian College of Surgeons, Royal College of Surgeons of Canada, Society of Thoracic Surgeons, and International Society for Rotary Pumps, among others.
He was the project director for CorAide LVAD and completed the development of the CorAide clinical system for temporary and permanent cardiac assist. He holds numerous patents for cardiac devices.
Leonard Golding is a Staff physician in the Department of Thoracic and Cardiovascular Surgery at Cleveland Clinic's main campus. He has held this position since 1977. Dr. Golding is also on Staff in the Department of Biomedical Engineering at Cleveland Clinic. Prior to 1997, he was an associate staff physician in Department of Thoracic and Cardiovascular Surgery at Cleveland Clinic. Dr. Golding is an international speaker and published author. His research has been published in leading peer-reviewed journals and he has contributed chapters to medical textbooks in his field.
Dr. Golding is a member of the American Association for Advancement of Science, American College of Cardiology, American Heart Association, American Institute for Medical & Biological Engineering, American Medical Association, American Society for Artificial Internal Organs, Royal Australian College of Surgeons, Royal College of Surgeons of Canada, Society of Thoracic Surgeons, and International Society for Rotary Pumps, among others.
He was the project director for CorAide LVAD and completed the development of the CorAide clinical system for temporary and permanent cardiac assist. He holds numerous patents for cardiac devices.
Eugene Jung - Management Advisor
Gene Jung has over 17 years experience in research, development, and commercialization of a wide variety of cardiac catheters including balloons, catheter delivery platforms, stents, and energy/drug delivery technologies. Most recently he was VP of Engineering at ProRhythm, Inc. in New York. His prior experience was with Jomed, EndoSonics, Navius, Heart Rhythm Technologies, Medtronic Interventional Vascular and as an independent medical device consultant in Japan. He has over 20 patents and pending patents in cardiac catheters and related technologies.
Gene Jung has over 17 years experience in research, development, and commercialization of a wide variety of cardiac catheters including balloons, catheter delivery platforms, stents, and energy/drug delivery technologies. Most recently he was VP of Engineering at ProRhythm, Inc. in New York. His prior experience was with Jomed, EndoSonics, Navius, Heart Rhythm Technologies, Medtronic Interventional Vascular and as an independent medical device consultant in Japan. He has over 20 patents and pending patents in cardiac catheters and related technologies.